In hormone-responsive cells expressing both AR and ER (α and/or β), such as prostate and breast cancers, AR/ER/Src association plays a crucial role in activation of Src signals triggered by EGF and/or sex hormones (25,28). The gene discussed is AR; the disease is breast cancer.